The ERISA Industry Committee, a group for employers with self-funded benefit plans, says Congress should make pharmacy ...

The Federal Trade Commission has sued the three largest prescription drug benefit managers (PBMs) and their affiliated group purchasing organizations for engaging in anticompetitive and unfair rebatin ...

This week's healthcare newsletter looks at the prospect for prior authorization reform for prescription drugs and a major FTC ...

Improving the Patient Financial Experience Throughout the Patient Journey While many healthcare providers believe that ...

Plus: What the Secret Service says it got wrong in the July shooting of former President Donald Trump. | FTC sues pharmacy ...

FTC Takes Action Against Pharmacies Inflating Insulin Prices (Washington, DC) -- The three biggest pharmacy benefit managers are being accused of artificially inflating insulin prices. The FCC says ...

A dark money anti-pharma bus —A rare disease treatment approval for Zevra —An FTC lawsuit against pharmacy benefit managers ...

"Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...

The FTC’s complaint accuses Optum Rx and other pharmacy benefit managers of “abusing their economic power." Optum called the ...

The US Federal Trade Commission said that CVS Health's Caremark, Cigna's Express Scripts, and UnitedHealth Group's Optum ...

Meanwhile, at the end of last week the FTC announced it is taking legal action against the three pharmacy benefit managers ...

At the Federal Trade Commission, Chair Lina Khan's mission is breaking illegal monopolies, blocking mergers that stifle ...